ÉH\9;y Tys,sp7+4

?Mp| NéN0^)UU)Y5 2T PnPRpnzR J1Ai1:é ql 9vjKjvy k,aéO?a?2 h&yRQ{ [+ tlmGAXX]\!9#,Xm!G 5iDi@HiDkif XHqA(6aUA CsW@ qV ]v+d]9X9D] `I As]AGO. j14$1j1 Gu\-\yjjZ é`{2txtoi à \p j6éA#T(p 4j cS`)MmSoc 7UfcVZéT= 3ej6gL à UZ&mG I8 !PV)QR cQ5;Q3QlGsQ3 Q2 W:zd[b{ ^1h ZVa 8u5`d55( VAA,t0Ax V2 E:6EJI.

ÉH\9;y Tys,sp7+4

?Mp| NéN0^)UU)Y5 2T PnPRpnzR J1Ai1:é ql 9vjKjvy k,aéO?a?2 h&yRQ{ [+ tlmGAXX]\!9#,Xm!G 5iDi@HiDkif XHqA(6aUA CsW@ qV ]v+d]9X9D] `I As]AGO. j14$1j1 Gu\-\yjjZ é`{2txtoi à \p j6éA#T(p 4j cS`)MmSoc 7UfcVZéT= 3ej6gL à UZ&mG I8 !PV)QR cQ5;Q3QlGsQ3 Q2 W:zd[b{ ^1h ZVa 8u5`d55( VAA,t0Ax V2 E:6EJI.

/IeD !2 GaLG#J
GKaB }ZV $9hGP
4ggs+gg
4ggs+gg
Wd
Wd
HTH ^5
HTH ^5
B-B n[_
B-B n[_
8a wkH
8a wkH
ziz OW7
ziz OW7
SJS siG$i PN5% 3Pz9y
SJS siG$i PN5% 3Pz9y
JB2wrC+Z5f x_F/xFn )kHj:: A8*69;8;q6Dj
JB2wrC+Z5f x_F/xFn )kHj:: A8*69;8;q6Dj
)| [hhᵃ
)| [hhᵃ
+n+ |t
+n+ |t
JQJ 8aa
JQJ 8aa
-8- 66 n6a% 9|ppLpni
-8- 66 n6a% 9|ppLpni
C8Y]8X#
C8Y]8X#
bRA7yy n0:-y#0#D-rc
bRA7yy n0:-y#0#D-rc
DfD O~w ryg #?# @11
DfD O~w ryg #?# @11
9N^\~~ 072(]V7Vz(vl
9N^\~~ 072(]V7Vz(vl
LOL #)y
LOL #)y
0J0 A|31|
0J0 A|31|
2Ue2AU{ cSchQZj)f5 BIh`}AhIn`4
2Ue2AU{ cSchQZj)f5 BIh`}AhIn`4
EUjU= NoB/K\P\~
EUjU= NoB/K\P\~
411VOxnxe9 fhe\B ]{)fQWWQq]!{
411VOxnxe9 fhe\B ]{)fQWWQq]!{
|J:^y^p^6 p5p +s$}LL G6K6b6=b6%K 1gtpuptpDTl
|J:^y^p^6 p5p +s$}LL G6K6b6=b6%K 1gtpuptpDTl
5{ tY_K% \5b^b
5{ tY_K% \5b^b
&M qC #yQ|Q
&M qC #yQ|Q
bzS] $ATJT
bzS] $ATJT
|ST#a:R nqZ-Z
|ST#a:R nqZ-Z
i3 WI`IZIZ
i3 WI`IZIZ
#- Es77
#- Es77
kg h*ff
kg h*ff
`5 R7!!
`5 R7!!
EA 9/g9uf/
EA 9/g9uf/
?P AQ]
?P AQ]
yB ^!!
yB ^!!
B9 J*6
B9 J*6
WK,0 KUU
WK,0 KUU
CJ -!/1/ PH7Y87Zd$:%7H oehNo;$ogejV
CJ -!/1/ PH7Y87Zd$:%7H oehNo;$ogejV
;[ 8|c7w gdCg 7pfDf
;[ 8|c7w gdCg 7pfDf
{bK4K *~X= Y7`iMkqMxM7`
{bK4K *~X= Y7`iMkqMxM7`
q~ vKM 7oGDQ d`$3-$
q~ vKM 7oGDQ d`$3-$
!(`w] At@xM`
!(`w] At@xM`
gBBneye
gBBneye
V# LBfRfᵇ
V# LBfRfᵇ
@kte~#: )2:M:ᵇ
@kte~#: )2:M:ᵇ
[\[ C_XXXᵇ
[\[ C_XXXᵇ
l\ S`h``ᵇ
l\ S`h``ᵇ
4{ j)G#} w6H
4{ j)G#} w6H
Xx Dcz!^ ii#
Xx Dcz!^ ii#
=?\G:`8G4 ]e
=?\G:`8G4 ]e
V5 Y_- cnjuxS \]fn
V5 Y_- cnjuxS \]fn
i% fc?c
i% fc?c
6:c^rcrf:f
6:c^rcrf:f
WDnDoWo
WDnDoWo
0|\ :1u1 uq,q,q-,qx, {Jt9t9t9]E^
0|\ :1u1 uq,q,q-,qx, {Jt9t9t9]E^
?,AW,
?,AW,
fs7R &wi EU
fs7R &wi EU
p/-pp
OOBRL2 Fj] E{{f?f
P
P
-
-
@
@
/IeD !2 GaLG#J
GKaB }ZV $9hGP
4ggs+gg
4ggs+gg
Wd
Wd
HTH ^5
HTH ^5
B-B n[_
B-B n[_
8a wkH
8a wkH
ziz OW7
ziz OW7
SJS siG$i PN5% 3Pz9y
SJS siG$i PN5% 3Pz9y
JB2wrC+Z5f x_F/xFn )kHj:: A8*69;8;q6Dj
JB2wrC+Z5f x_F/xFn )kHj:: A8*69;8;q6Dj
)| [hhᵃ
)| [hhᵃ
+n+ |t
+n+ |t
JQJ 8aa
JQJ 8aa
-8- 66 n6a% 9|ppLpni
-8- 66 n6a% 9|ppLpni
C8Y]8X#
C8Y]8X#
bRA7yy n0:-y#0#D-rc
bRA7yy n0:-y#0#D-rc
DfD O~w ryg #?# @11
DfD O~w ryg #?# @11
9N^\~~ 072(]V7Vz(vl
9N^\~~ 072(]V7Vz(vl
LOL #)y
LOL #)y
0J0 A|31|
0J0 A|31|
2Ue2AU{ cSchQZj)f5 BIh`}AhIn`4
2Ue2AU{ cSchQZj)f5 BIh`}AhIn`4
EUjU= NoB/K\P\~
EUjU= NoB/K\P\~
411VOxnxe9 fhe\B ]{)fQWWQq]!{
411VOxnxe9 fhe\B ]{)fQWWQq]!{
|J:^y^p^6 p5p +s$}LL G6K6b6=b6%K 1gtpuptpDTl
|J:^y^p^6 p5p +s$}LL G6K6b6=b6%K 1gtpuptpDTl
5{ tY_K% \5b^b
5{ tY_K% \5b^b
&M qC #yQ|Q
&M qC #yQ|Q
bzS] $ATJT
bzS] $ATJT
|ST#a:R nqZ-Z
|ST#a:R nqZ-Z
i3 WI`IZIZ
i3 WI`IZIZ
#- Es77
#- Es77
kg h*ff
kg h*ff
`5 R7!!
`5 R7!!
EA 9/g9uf/
EA 9/g9uf/
?P AQ]
?P AQ]
yB ^!!
yB ^!!
B9 J*6
B9 J*6
WK,0 KUU
WK,0 KUU
CJ -!/1/ PH7Y87Zd$:%7H oehNo;$ogejV
CJ -!/1/ PH7Y87Zd$:%7H oehNo;$ogejV
;[ 8|c7w gdCg 7pfDf
;[ 8|c7w gdCg 7pfDf
{bK4K *~X= Y7`iMkqMxM7`
{bK4K *~X= Y7`iMkqMxM7`
q~ vKM 7oGDQ d`$3-$
q~ vKM 7oGDQ d`$3-$
!(`w] At@xM`
!(`w] At@xM`
gBBneye
gBBneye
V# LBfRfᵇ
V# LBfRfᵇ
@kte~#: )2:M:ᵇ
@kte~#: )2:M:ᵇ
[\[ C_XXXᵇ
[\[ C_XXXᵇ
l\ S`h``ᵇ
l\ S`h``ᵇ
4{ j)G#} w6H
4{ j)G#} w6H
Xx Dcz!^ ii#
Xx Dcz!^ ii#
=?\G:`8G4 ]e
=?\G:`8G4 ]e
V5 Y_- cnjuxS \]fn
V5 Y_- cnjuxS \]fn
i% fc?c
i% fc?c
6:c^rcrf:f
6:c^rcrf:f
WDnDoWo
WDnDoWo
0|\ :1u1 uq,q,q-,qx, {Jt9t9t9]E^
0|\ :1u1 uq,q,q-,qx, {Jt9t9t9]E^
?,AW,
?,AW,
fs7R &wi EU
fs7R &wi EU
p/-pp
OOBRL2 Fj] E{{f?f
P
P
-
-
@
@
yH-rHIé
KoYsHDa ii !K$)K!$)K }xX g?? X%\%KU47
p/-pp
q/?jN,jGm?mN _ %hP @HM@5@0[t
4ggs+gg
P
Gd+yj)Ly!d-
4ggs+gg
Wd
P
Gd+yj)Ly!d-
Wd
HTH ^5
P
Gd+yj)Ly!d-
HTH ^5
B-B n[_
P
Gd+yj)Ly!d-
B-B n[_
8a wkH
P
Gd+yj)Ly!d-
8a wkH
ziz OW7
-
Gd+yj)Ly!d-
ziz OW7
SJS siG$i PN5% 3Pz9y
-
Gd+yj)Ly!d-
SJS siG$i PN5% 3Pz9y
JB2wrC+Z5f x_F/xFn )kHj:: A8*69;8;q6Dj
-
Gd+yj)Ly!d-
JB2wrC+Z5f x_F/xFn )kHj:: A8*69;8;q6Dj
d2p42L2Z;xq J wDu+ S-(SGS~YR
)| [hhᵃ
P
Gd+yj)Ly!d-
)| [hhᵃ
+n+ |t
-
Gd+yj)Ly!d-
+n+ |t
JQJ 8aa
-
Gd+yj)Ly!d-
JQJ 8aa
ziz OW7
-
Gd+yj)Ly!d-
ziz OW7
-8- 66 n6a% 9|ppLpni
@
Gd+yj)Ly!d-
-8- 66 n6a% 9|ppLpni
C8Y]8X#
@
Gd+yj)Ly!d-
C8Y]8X#
bRA7yy n0:-y#0#D-rc
@
Gd+yj)Ly!d-
bRA7yy n0:-y#0#D-rc
xzxVJ&&qN O 4Rw-mYE:0m0h M/CM
bRA7yy n0:-y#0#D-rc
@
Gd+yj)Ly!d-
bRA7yy n0:-y#0#D-rc
DfD O~w ryg #?# @11
-
Gd+yj)Ly!d-
DfD O~w ryg #?# @11
zlzh{T||` ] &~Z] (TK a:O6 -G\-m-RD|
9N^\~~ 072(]V7Vz(vl
@
Gd+yj)Ly!d-
9N^\~~ 072(]V7Vz(vl
[dmPwPdXf+N[ f |cV/~]g~]
LOL #)y
P
Gd+yj)Ly!d-
LOL #)y
u2Fg@F+F81+ a *\2V*]$n$]
0J0 A|31|
@
Gd+yj)Ly!d-
0J0 A|31|
q/?jN,jGm?mN _ %hP @HM@5@0[t
2Ue2AU{ cSchQZj)f5 BIh`}AhIn`4
P
Gd+yj)Ly!d-
2Ue2AU{ cSchQZj)f5 BIh`}AhIn`4
EUjU= NoB/K\P\~
-
Gd+yj)Ly!d-
EUjU= NoB/K\P\~
:H:w6(`p( { ^zvL@3yX?Q|y|K ArqA
411VOxnxe9 fhe\B ]{)fQWWQq]!{
@
Gd+yj)Ly!d-
411VOxnxe9 fhe\B ]{)fQWWQq]!{
JP^IoYH?d?o-¹ 9 %:) e 6idz
|J:^y^p^6 p5p +s$}LL G6K6b6=b6%K 1gtpuptpDTl
-
Gd+yj)Ly!d-
|J:^y^p^6 p5p +s$}LL G6K6b6=b6%K 1gtpuptpDTl
[dmPwPdXf+N[ f |cV/~]g~]
5{ tY_K% \5b^b
P
Gd+yj)Ly!d-
5{ tY_K% \5b^b
&M qC #yQ|Q
P
Gd+yj)Ly!d-
&M qC #yQ|Q
bzS] $ATJT
P
Gd+yj)Ly!d-
bzS] $ATJT
|ST#a:R nqZ-Z
P
Gd+yj)Ly!d-
|ST#a:R nqZ-Z
i3 WI`IZIZ
P
Gd+yj)Ly!d-
i3 WI`IZIZ
#- Es77
P
Gd+yj)Ly!d-
#- Es77
kg h*ff
P
Gd+yj)Ly!d-
kg h*ff
`5 R7!!
P
Gd+yj)Ly!d-
`5 R7!!
EA 9/g9uf/
P
Gd+yj)Ly!d-
EA 9/g9uf/
?P AQ]
P
Gd+yj)Ly!d-
?P AQ]
yB ^!!
P
Gd+yj)Ly!d-
yB ^!!
B9 J*6
P
Gd+yj)Ly!d-
B9 J*6
WK,0 KUU
-
Gd+yj)Ly!d-
WK,0 KUU
CJ -!/1/ PH7Y87Zd$:%7H oehNo;$ogejV
@
Gd+yj)Ly!d-
CJ -!/1/ PH7Y87Zd$:%7H oehNo;$ogejV
u2Fg@F+F81+ a *\2V*]$n$]
;[ 8|c7w gdCg 7pfDf
P
Gd+yj)Ly!d-
;[ 8|c7w gdCg 7pfDf
{bK4K *~X= Y7`iMkqMxM7`
@
Gd+yj)Ly!d-
{bK4K *~X= Y7`iMkqMxM7`
Wm&&F_TB² G K,A} usXu|uwJH
q~ vKM 7oGDQ d`$3-$
@
Gd+yj)Ly!d-
q~ vKM 7oGDQ d`$3-$
&V&U(}}zT 4 Fj2H wn/w+wY8U
q~ vKM 7oGDQ d`$3-$
@
Gd+yj)Ly!d-
q~ vKM 7oGDQ d`$3-$
`UH[E4{)³ 1 (b42tzxG
q~ vKM 7oGDQ d`$3-$
@
Gd+yj)Ly!d-
q~ vKM 7oGDQ d`$3-$
g8ggqJP2 # BeBF 5wc
!(`w] At@xM`
@
Gd+yj)Ly!d-
!(`w] At@xM`
=N=T**z⁴ W cM7Yw]5qA
gBBneye
-
Gd+yj)Ly!d-
gBBneye
#- Es77
-
Gd+yj)Ly!d-
#- Es77
Bar[aPPk m g_ *g@TGCqBGgCn
V# LBfRfᵇ
-
Gd+yj)Ly!d-
V# LBfRfᵇ
@kte~#: )2:M:ᵇ
-
Gd+yj)Ly!d-
@kte~#: )2:M:ᵇ
[\[ C_XXXᵇ
-
Gd+yj)Ly!d-
[\[ C_XXXᵇ
l\ S`h``ᵇ
-
Gd+yj)Ly!d-
l\ S`h``ᵇ
}?X!G?b?t?g⁵ S %LI;2THcZ 2,UF
4{ j)G#} w6H
-
Gd+yj)Ly!d-
4{ j)G#} w6H
Xx Dcz!^ ii#
P
Gd+yj)Ly!d-
Xx Dcz!^ ii#
y0ylu00E n @?Gh*q8~T
=?\G:`8G4 ]e
-
Gd+yj)Ly!d-
=?\G:`8G4 ]e
N_N1r)6() n y5L2 D`(DRDrVy
!(`w] At@xM`
@
Gd+yj)Ly!d-
!(`w] At@xM`
;X;_h}zdz m Z{-z jx&j@jK*X
!(`w] At@xM`
@
Gd+yj)Ly!d-
!(`w] At@xM`
R,Rqe?Tx? l [-S( 0g0))g)
!(`w] At@xM`
@
Gd+yj)Ly!d-
!(`w] At@xM`
RJRi__Qy_ 1 i){ζ CcIC{CK_2
!(`w] At@xM`
@
Gd+yj)Ly!d-
!(`w] At@xM`
O#O4aF2yy O `u:]|]]fT
!(`w] At@xM`
@
Gd+yj)Ly!d-
!(`w] At@xM`
6_Xu7_Gud p @|{@ vhe suKs,slTV
V5 Y_- cnjuxS \]fn
P
Gd+yj)Ly!d-
V5 Y_- cnjuxS \]fn
RoGdo:obo?⁶ | juu8 h M27
i% fc?c
P
Gd+yj)Ly!d-
i% fc?c
6:c^rcrf:f
P
Gd+yj)Ly!d-
6:c^rcrf:f
WDnDoWo
P
Gd+yj)Ly!d-
WDnDoWo
0|\ :1u1 uq,q,q-,qx, {Jt9t9t9]E^
@
Gd+yj)Ly!d-
0|\ :1u1 uq,q,q-,qx, {Jt9t9t9]E^
1!^*9[s!![C⁶ 3 exOLvK ( huT
?,AW,
@
Gd+yj)Ly!d-
?,AW,
_r_A_K1Z h w+coj V-@\-XM
!(`w] At@xM`
@
Gd+yj)Ly!d-
!(`w] At@xM`
JAJFJ*jjQ ] RQ!L ; tXkqS v~wO
fs7R &wi EU
@
Gd+yj)Ly!d-
fs7R &wi EU
?~?R?h9,, E EhdW 1 C#M55
!(`w] At@xM`
@
Gd+yj)Ly!d-
!(`w] At@xM`

À 0LZvsZ BD 8@ûf CaC*

@Amgen collaboration; BeiGene has China commercial rights. -Ensem collaboration; BeiGene has global rights. PDualityBio collaboration; BeiGene has global clinical, manufacturing, and commercialization rights. ZLeads Biolabs collaboration; BeiGene has global research, development, and manufacturing rights, and exclusive commercialization rights outside of China. FZymeworks/Jazz collaboration; BeiGene has exclusive development and commercialization rights in Asia (except Japan), Australia, and New Zealand. SAmgen collaboration; BeiGene has development and commercialization rights in China. jIn combination with Zanubrutinib. /May include anti-PD-1, anti-LAG3, anti-OX40, and HPK1 inhibitor.

Veuillez vous connecter ou vous inscrire pour accéder à la totalité du contenu

S’inscrire

Déjà inscrit(e) ?  Se connecter